Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas.
Sabha N, Knobbe CB, Maganti M, Al Omar S, Bernstein M, Cairns R, Çako B, von Deimling A, Capper D, Mak TW, Kiehl TR, Carvalho P, Garrett E, Perry A, Zadeh G, Guha A, Sidney Croul.
Sabha N, et al. Among authors: kiehl tr.
Neuro Oncol. 2014 Jul;16(7):914-23. doi: 10.1093/neuonc/not299.
Neuro Oncol. 2014.
PMID: 24470545
Free PMC article.